Drug archive
Miglustat (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Substrate reduction therapy
Description
Miglustat ((MIH-glue-stat)) is used to treat adults with mild to moderate type 1Gaucher disease. Miglustat is only used in people who cannot be treated with enzyme replacement therapy. Type 1 Gaucher disease is a disease you get from both your parents. People with type 1 Gaucher disease are missing an enzyme (naturally occurring substance in your body) that breaks down a chemical in your body called glucosylceramide. Too much glucosylceramide causes liver and spleen enlargement, changes in the blood, and bone disease. Miglustat works by stopping the body from making glucosylceramide.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Capsules (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Zavesca
† Not commercially available in Canada.